Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases.
about
In silico prediction of inhibition of promiscuous breast cancer resistance protein (BCRP/ABCG2)MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration.Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancerA novel paradigm in the treatment of oligometastatic non-small cell lung cancer.Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexedThe role of microRNA-21 in predicting brain metastases from non-small cell lung cancer.Update in lung cancer and mesothelioma 2009.Brain metastases as preventive and therapeutic targets.miRNAs in lung cancer: large roles for small players.The evolving role of radiotherapy in treatment of oligometastatic NSCLC.Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer.Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitors.Aggressive Trimodality Therapy for T1N2M1 Nonsmall Cell Lung Cancer with Synchronous Solitary Brain Metastasis: Case Report and Rationale.Radiotherapy for Oligometastatic Lung Cancer.Machine Learning Based Prediction of Brain Metastasis of Patients with IIIA-N2 Lung Adenocarcinoma by a Three-miRNA Signature.Baseline insulin-like growth factor-I plasma levels, systemic inflammation, weight loss and clinical outcome in metastatic non-small cell lung cancer patients.Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cLong-term survival without surgery in NSCLC patients with synchronous brain oligometastasis: systemic chemotherapy revisited.Development and cross-validation of prognostic models to assess the treatment effect of cisplatin/pemetrexed chemotherapy in lung adenocarcinoma patients.MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis.Therapie von Hirnmetastasen und Meningeosis neoplasticaMiR-423-5p in brain metastasis: potential role in diagnostics and molecular biology
P2860
Q28540667-4D86657E-61BA-4B18-AED4-9ED94001710BQ33814564-2CE8303C-8EC0-4B47-A2B0-0C0532B70410Q34174258-D100FE2B-617A-40C4-93A9-27AF1A376FD4Q35121736-99795C71-43E8-45C4-B4DA-D0931E9C21C4Q35667792-1A3CFC4A-7079-4CD5-B25C-6B0915A53A09Q36070007-1A820EAF-BDD9-4917-9943-639D5265958EQ37551937-0E954485-FA7E-4DF8-92C8-8C866E540D36Q37728779-C2666D27-7D04-46A8-AC7D-60C3BBC17ADFQ37862581-A9EC126C-66CD-4799-B648-4AB2FD1D3FDEQ37932539-206131DE-6BDA-45A4-9C2C-D89C7C7F970CQ38625125-96A270D1-BF71-4546-9F6F-192B5C3654BFQ40313930-1D31AC79-D5DA-47A5-A7BF-3BBD00FB643EQ40498874-161F47A2-7483-4078-8C4A-9BB319D4B182Q41966112-68BC99FB-5059-4581-95B1-8055B7BF5259Q42109226-0DCBFF58-8E4D-4684-A302-83BBE0ABAFA0Q47172680-63AA370A-6507-41E8-8AFC-66C4EE95F04DQ47350544-AFC63B79-30C8-42A6-8B70-90C67C374E35Q52582229-852314A9-4B61-4CB6-94EC-E8D25F63377CQ52715757-98446B8C-844A-48BA-8CE4-CFDE8CAABB95Q54331093-0C4A9961-7D0D-4F73-AA34-7227F2261E3CQ54340906-730A6076-6EAD-477E-9F3B-4480C3CA507FQ58023833-C937233E-AF69-4007-A1ED-F0C9E296B115Q58734063-ECF13459-9745-46E9-A187-298D00C079F4
P2860
Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Number of metastatic sites is ...... h or without brain metastases.
@en
Number of metastatic sites is ...... h or without brain metastases.
@nl
type
label
Number of metastatic sites is ...... h or without brain metastases.
@en
Number of metastatic sites is ...... h or without brain metastases.
@nl
prefLabel
Number of metastatic sites is ...... h or without brain metastases.
@en
Number of metastatic sites is ...... h or without brain metastases.
@nl
P2093
P2860
P356
P1433
P1476
Number of metastatic sites is ...... h or without brain metastases.
@en
P2093
Benjamin Nebiyou Bekele
Daniel D Karp
David J Stewart
J Matthew Debnam
Pamela K Allen
Raymond Sawaya
Sarah Taylor
P2860
P304
P356
10.1002/CNCR.24333
P407
P577
2009-07-01T00:00:00Z